PARIS, France and SAN FRANCISCO, CA, July 17, 2025 – Moon Surgical has deployed its Maestro Platform at Lee Health’s Gulf Coast Medical Center in Fort Myers, Florida, where it has supported over 100 minimally invasive procedures, including bariatric and general surgeries. The rollout marks continued adoption of the system across U.S. hospitals seeking to improve workflow efficiency and resource utilization.
The hospital reported:
- Zero adverse events
- No increase in operative time or length of stay, even in the initial cases
- Operational efficiencies which enable the reduction of one surgical technologist per case without compromising care
In the first 25 bariatric cases, Maestro helped Lee Health save the equivalent of 8.3 working days of surgical tech time, demonstrating its impact on staffing efficiency and resource optimization.
Juan Ibarra, M.D, robotic surgery program manager at Lee Heath commented: “We’re proud to be among the early U.S. institutions to adopt the Maestro Platform. We’ve completed over 100 procedures, each one delivering excellent clinical and operational outcomes. For surgeons who prefer traditional laparoscopy, Maestro offers a smart and reliable assistant without changing their preferred surgical approach. We are proud at Lee Health to be setting the pace with technology that improves efficiency, maintains safety, and supports our teams.”
“The program launch and partnership with Lee Health is a great example of how Maestro is defining a new category of MIS.” said Anne Osdoit, CEO of Moon Surgical. “Maestro has quickly delivered consistent and scalable positive impact for surgeons, their teams, the hospital system and its patients.”
The launch at Lee Health follows an announcement on the Maestro System’s usage, which has supported more than 1,600 procedures globally, including 1,400 in the past year, across 60 types of minimally invasive surgeries. Maestro’s adoption shows its adaptability across specialties and its utility in outpatient care.
Maestro is a surgical technology platform powered by Physical AI. It is designed to support surgical teams by enhancing adaptability, providing control, and integrating with current operating room workflows.
Source: Moon Surgical
About Moon Surgical
Moon Surgical, founded in 2020, is a medical technology company headquartered in Paris with additional operations in San Carlos, CA. The company develops the Maestro surgical robotics system and Maestro Insights software to support minimally invasive soft-tissue procedures. Designed for use in general, bariatric and gynecological surgeries, the system assists surgical teams with enhanced control, haptics and data integration. Moon Surgical operates in the surgical robotics and medical device sectors, serving hospitals and ambulatory surgery centers. The company employs approximately 110 people and reports an estimated annual revenue of $27.6 million. It has raised more than $86 million in funding and holds both FDA clearance and CE marking for the Maestro platform. With a focus on system interoperability, data-driven insights and streamlined workflows, Moon Surgical aims to make robot-assisted surgery more accessible and adaptable for surgical teams and healthcare systems worldwide.